Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 3Withdrawn 2Terminated 2Recruiting 2Suspended 1

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 1

Conditions

Thalassemia 1Neoplasms 1Leukemia, Myeloid, Acute 1Hemorrhage 1Hematologic Neoplasms 1Bronchiolitis Obliterans Syndrome 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Blood Transfusion × Clear all
NCT04294641 2026-01-23

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 15 charts
Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT05255445 2024-05-17

RBC-IMPACT

Westat

Completed
157 enrolled
Classical hematology

Anemia, Sickle Cell, Neoplasms, Thalassemia

NCT05452538 2024-02-26

ATTRACS

Centre Leon Berard

Completed
5,808 enrolled

Hemorrhage

NCT02845232 2016-07-27

Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly

Hospices Civils de Lyon

Completed
214 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡